Patents
Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
08/2002
08/28/2002EP1233967A1 Pyridinones to treat and prevent bacterial infections
08/27/2002US6440962 Cardiovascular disorders, antiischemic agents
08/27/2002US6440961 Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
08/22/2002US20020115853 6-(3-nitrophenyl)-3H-benzooxazol-2-one for example; contraceptives, treating hormone dependent tumors, endometriosis; progesterone receptor agonists and antagonists
08/22/2002US20020115657 Such as 3-(4-(2-(10,11-dihydro-dibenzo(b,f)azepin-5-yl)-ethoxy)-phenyl)-2 -ethoxypropionic acid; for treatment/ prevention of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
08/21/2002EP1233017A1 Tricyclic sulfonamides useful as matrix metalloproteinase inhibitors
08/21/2002EP1233016A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors
08/20/2002US6436927 IL-8 receptor antagonists
08/15/2002WO2002062772A1 Salts of 3-4(4-(2-phenoxazin- or phenothiazin-10-yl)alkoxy)phenyl)-2-alkoxypropanoic acid derivatives with ppar activity for the treatment of hyperlipimedia and type ii diabetes
08/15/2002WO2002020498A3 An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine
08/15/2002US20020111501 Oxidizing N,N'-dimethyl-phenylene-diamine in the presence of a source of thiosulfate ions, while maintianing at </= 100 degrees C, oxidizing and condensing with o-toluidine, and separating toluidine blue
08/15/2002US20020111344 Antidiabetic agetns, dietetics
08/14/2002CA2371481A1 Sulfonamide matrix metalloproteinase inhibitors
08/14/2002CA2371480A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors
08/13/2002US6432947 N-heterocyclic derivatives as NOS inhibitors
08/08/2002US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002CN1362397A Dialkoyl-halogen phenyl substituted keto-enol
08/06/2002US6429206 Using agonist of nicotinergic acetylcholine receptors
08/01/2002US20020103191 Antitumor dibenzofluorene derivatives
08/01/2002US20020103189 Nitrogen-containing tricyclic compounds and drugs containing the same
08/01/2002US20020103188 Peroxisome Proliferator-Activated Receptors (PPAR); diabetes and obesity; 3-(4-(2-(10,1-Dihydro-dibenzo(b,f)azepin-5-yl)ethoxy)-pheny)-2-ethoxy -propionic acid, for example
08/01/2002US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002US20020102310 Phenothiazine in prill form and method for making the same
07/2002
07/31/2002EP0817969B1 Inhibition of tau-tau-association
07/25/2002WO2002057244A1 Phenothiazine kinesin inhibitors
07/25/2002WO2002057218A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
07/25/2002US20020099084 Pharmaceutically active compounds and methods of use
07/24/2002EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same
07/23/2002US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides
07/23/2002US6423699 Contraceptives
07/18/2002US20020094980 Preparing 1,1-dioxo-2-phenyl-3-carboxy-4-phenyl-1,2-benzo(e)-thiazines by a five-step process starting with a (2-(methyl-oxycarbonyl-)phenyl-sulfonamido-)benzene; alkylation; cyclization; hydroxylation; esterification and coupling
07/17/2002CN1358712A Productive process for Rufloxaxin Hydrochloride raw material
07/11/2002US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides
07/11/2002US20020091118 Psychotherapeutic agents.
07/11/2002US20020091117 Psychotherapeutic agents.
07/09/2002US6417370 Arylphenyl-substituted cyclic keto-enols
07/09/2002US6417362 Piperazine derivatives; arteriosclerosis, pancreatitis, and cardiovascular disorder treatment; side effect reduction
07/04/2002US20020086853 Treatment of inflammatory disorders
07/03/2002EP1219612A1 2-imino-1,3-thiazine derivatives
07/03/2002EP0915837B1 Glyoxylic acid derivatives
07/02/2002USRE37781 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/02/2002CA2047382C Stabilized monomer compositions
06/2002
06/27/2002WO2002050050A1 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy)ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof
06/27/2002WO2002050049A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same
06/27/2002US20020082258 Novel antitobesity and hypocholesterolemic compounds lower total cholesterol; increase high density lipoprotein (HDL) and decrease low denstiy lipoprotein
06/27/2002CA2432807A1 1,1-dioxo-2h-1, 2-benzothiazine-3-carboxamide derivatives, method for preparing same and pharmaceutical compositions comprising same
06/26/2002EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists
06/25/2002CA2051156C Mixtures and compositions containing phenothiazines
06/20/2002US20020077337 Chemical compounds
06/20/2002US20020077320 For use as hypolipidemic, antihyperglycemic compounds
06/18/2002US6407231 Cyclization of diphenylamine compound; one pot process
06/18/2002US6407100 Fungicidal aromatic oximes
06/18/2002US6406913 Analyzing a sample, treating with energy and detection a signal
06/13/2002WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002US20020072519 Useful as psychotherapeutic agents
06/13/2002CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/12/2002EP1212119A1 Use of cyamemazine for cold turkey benzodiazepine treatment
06/12/2002CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
06/12/2002CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/11/2002US6403592 Serotonin reuptake inhibitors
06/05/2002EP1210333A2 Novel herbicides
06/05/2002CN1352639A Novel tricyclic compounds and their use in medicine, process for their production and pharmaceutical composition containing them
05/2002
05/30/2002WO2002004444A3 Heterocycle carboxamides as antiviral agents
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/28/2002US6395730 Potassium channel inhibitors
05/28/2002US6395367 Electroconductivity
05/23/2002WO2002040460A1 A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate
05/23/2002WO2001072707A3 Carbamate caspase inhibitors and uses thereof
05/23/2002US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation
05/22/2002EP1206467A1 N-heterocyclic derivatives as nos inhibitors
05/16/2002US20020058280 Metal chelate containing compositions for use in chemiluminescent assays
05/15/2002EP1204648A1 N-oxyl radicals
05/15/2002CN1349511A Benzimidazolrone and analogues, and the use as ligand of progesterone
05/15/2002CN1349411A Compositions containing benzimidazolones and progestogens
05/14/2002US6388127 Cyclization using dehydration agent
05/14/2002CA2214829C Methods and compositions for in-vivo detection of oral cancers and precancerous conditions
05/10/2002WO2002028868A8 Thiazine derivatives
05/07/2002US6384075 Treating diseases in which mast cell dysfunction is involved
05/07/2002US6384056 Cognition activators and nerve and vision disorders
05/02/2002EP1201650A2 Ionic malonitril derivatives and their uses
04/2002
04/30/2002US6380246 For combating pests and weeds
04/30/2002US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy
04/30/2002US6380186 Psychotherapeutic agents
04/30/2002US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
04/30/2002CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
04/25/2002US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression
04/25/2002US20020049211 Combination treatment for depression and anxiety
04/25/2002US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family
04/23/2002US6376205 Contacting tau protein or derivative bound to solid phase with agent suspected of being modulator or inhibitor of tau-tau association and material which binds to said protein, detecting binding, wherein decrease indicates modulation
04/18/2002WO2002030929A1 Novel pleuromutilin derivatives
04/18/2002WO2002030914A1 Salts of benzothiazine and benzoxazine derivatives and pharmaceutical compositions containing them
04/18/2002US20020045641 Multiple heteroatom containing heterocyclic ring compounds substituted with carboxylic acids and isosteres thereof
04/18/2002DE10122447A1 Biphenylcarboxamide Biphenylcarboxamides
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/17/2002CN1345241A In vivo stain compounds and methods of use to identify dysplastic tissue
04/16/2002US6372904 Oxidizing n,n'-dimethyl-p-phenylene diamine in first reaction mixture, introducing sodium thiosulfate ions to form 2-amino-5-dimethylaminophenyl thiosulfonic acid, oxiding the intermediate with o-toludine to form second intermediate
04/11/2002WO2002028868A1 Thiazine derivatives
04/11/2002WO2002028846A1 Cyclic sulfonyl compounds as inhibitors of metalloproteases
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 52